Clinical Trial Update: The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery [Phase 3]

View source ↗

Summary

Phase III clinical study of herombopag for thrombocytopenia in chronic liver disease patients undergoing elective invasive surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery

Drugs mentioned

• Herombopag (herombopag)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery | Phase 3 | Status: COMPLETED